Your search returned 212 studies. (Get alerts for new studies):
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization
Conditions: Melanoma
1 Location available
- Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-1
Conditions: Ocular Melanoma
1 Location available
- Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Melanoma (Skin)
7 Locations available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
Conditions: Mucosal Melanoma - Acral/Lentiginous Melanoma
5 Locations available
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Conditions: Esophageal Cancer - Bile Duct Neoplasms - Gastric Cancer - Liver Cancer - Melanoma - Pancreatic Cancer - Sarcoma
1 Location available
- Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms - Colorectal or Kidney Neoplasms - Pancreatic Neoplasms - Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive - Melanoma - CLL
1 Location available
- A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma Or Melanoma
Conditions: Neuroblastoma - Melanoma
1 Location available
- Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Conditions: Choroidal Melanoma
1 Location available
- Feasibility and Functionality of fPAM Imaging in Melanoma
Conditions: Melanoma
1 Location available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Pilot Study of IFN α2b for Melanoma Patients
Conditions: Melanoma
1 Location available
- Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
Conditions: Intraocular Melanoma
1 Location available
- Study of Weekly LOC-paclitaxel Injection for Melanoma
Conditions: Melanoma
1 Location available
- Phase II Study of Tesetaxel in Metastatic Melanoma
Conditions: Advanced Melanoma - Cancer
1 Location available
- SciBase International Melanoma Pivotal Study
Conditions: Malignant Melanoma
1 Location available
- Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH
Conditions: Melanoma
1 Location available
- High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Conditions: Malignant Melanoma
1 Location available
- Evaluation of a Simulation Training Tool to Identify Lesions Requiring Further Screening for Melanoma
Conditions: Skin Simulation Model - Mastery Learning Model to Simulation Training for Visual Screening for Melanoma and Skin Biopsy
1 Location available
- A Study of PNT2258 in Patients With Advanced Solid Tumors
Conditions: Cancer - Lymphoma - Prostate - Melanoma
1 Location available
- Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma
Conditions: Melanoma
1 Location available
- Characterization of the Melanoma-Specific Immune Response
Conditions: Melanoma
1 Location available
- Sample Collection From Melanoma Patients
Conditions: Melanoma
1 Location available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF
Conditions: Uveal Melanoma - Liver Metastases
1 Location available
- Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
Conditions: Non-Melanomatous Skin Cancer
1 Location available
- A Novel Treatment for Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma
Conditions: Melanoma
3 Locations available
- Chemotherapy and Total-Body Irradiation Followed By Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Vaccine Therapy in Treating Patients W
Conditions: Melanoma (Skin)
1 Location available
- Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma
Conditions: Melanoma
1 Location available
- Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma
2 Locations available
- Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
Conditions: Melanoma
1 Location available
- Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Melanoma
Conditions: Unresectable Stage III and Stage IV Melanoma
1 Location available
- Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Conditions: Melanoma
1 Location available
- Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
Conditions: Melanoma
2 Locations available
- Temozolomide or MEK Inhibitor AZD6244 (Selumetinib) in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Intraocular Melanoma
10 Locations available
- A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma (CC# 10852)
Conditions: Melanoma
1 Location available
- RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Conditions: Malignant Melanoma
3 Locations available
- Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)
Conditions: Choroidal Melanoma
1 Location available
- Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475
Conditions: Cancer, Solid Tumor
13 Locations available
- Vaccine Therapy With or Without Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
Conditions: Cutaneous Melanoma
1 Location available
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Ple
Conditions: Sarcoma - Melanoma - Epithelial Malignancies - Pleural Malignancies
1 Location available
- Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
Conditions: Neoplasm Metastases - Melanoma - Colorectal Neoplasms
1 Location available
- A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Conditions: Malignant Melanoma
8 Locations available
- Ph I/II Ipilimumab Vemurafenib Combo
Conditions: Melanoma
5 Locations available
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Conditions: Metastatic Renal Cell Carcinoma - Metastatic Melanoma
2 Locations available
- Study of Individuals and Families at High Risk for Cancer
Conditions: Bladder Cancer - Brain and Central Nervous System Tumors - Chordoma - Lung Cancer - Non-melanomatous Skin Cancer - Retinoblastoma - Sarcoma
2 Locations available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cytogenetic Study of Ocular Melanoma
Conditions: Choroidal Melanoma
1 Location available
- Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
Conditions: Metastatic Malignant Uveal Melanoma
4 Locations available
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
Conditions: High-Grade Glioma - Lung Cancer - Head & Neck Cancer - Sarcoma - Melanoma
1 Location available
- Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Conditions: Melanoma
1 Location available
- Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Conditions: Advanced Non-hematologic Malignancies - Advanced Metastatic Melanoma
2 Locations available
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
220 Locations available
- Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100/MART
Conditions: Melanoma
1 Location available
- A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Conditions: Melanoma
16 Locations available
- Can We Miss Pigmented Lesions in Psoriasis Patients?
Conditions: Psoriasis - Melanoma - Non-melanoma Skin Cancer
1 Location available
- Panobinostat (LBH589) in Patients With Metastatic Melanoma
Conditions: Melanoma - Malignant Melanoma
1 Location available
- Study of Denileukin Diftitox in Patients With Stage IIIC and Stage IV Melanoma
Conditions: Stage IIIC Melanoma - Stage IV Melanoma
10 Locations available
- An Open-Label, 2-Cohort, Multicenter, Study of E7080 in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Conditions: Unresectable Stage III or Stage IV Melanoma
77 Locations available
- STA-9090 in Metastatic Ocular Melanoma
Conditions: Ocular Melanoma
2 Locations available
- Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
Conditions: Melanoma - Ovarian Cancer - Sarcoma - BONE - CNS-SPINAL CD/MEMBR,NOS - LYMPH NODES - SOFT TISSUE
1 Location available
- Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Conditions: Colorectal Neoplasms - Neuroendocrine Tumors - Cholangiocarcinoma - Melanoma - Breast Cancer
1 Location available
- Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Conditions: Recurrence of Solid Tumor - Glioblastoma Multiforme - Melanoma
3 Locations available
- Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
Conditions: Recurrent Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
1 Location available
- A Study of Oral LGK974 in Patients With Melanoma and Lobular Breast Cancer
Conditions: Melanoma - Breast Neoplasms - Lobular Carcinoma
1 Location available
- Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Conditions: Melanoma - Merkel Cell Carcinoma - Squamous Cell Carcinoma - Penile Carcinoma - Urethral Carcinoma - Extramammary Paget's Disease - Scrotal Carcinoma - Anal Cancer - Vulvar Cancer - Skin Cancer - Lymphadenopathy
1 Location available
- Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
Conditions: Melanoma
1 Location available
- Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Melanoma (Skin)
2 Locations available
- Clinical Trial of Sutent to Treat Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
Conditions: Metastatic Melanoma - Absence of CNS Metastases
1 Location available
- Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
Conditions: Melanoma
1 Location available
- Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Conditions: Mucosal Melanoma - Acral Melanoma - Melanoma
8 Locations available
- Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Conditions: Recurrent Melanoma - Stage IV Melanoma
1 Location available
- Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Conditions: Non-melanomatous Skin Cancer - Pancreatic Cancer - Small Intestine Cancer - Testicular Germ Cell Tumor
1 Location available
- Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Conditions: Metastatic Melanoma
1 Location available
- Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
Conditions: Melanoma
1 Location available
- SCRI TISSUE TESTING REGISTRY
Conditions: Melanoma - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
1 Location available
- Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Conditions: Melanoma
2 Locations available
- Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
Conditions: Melanoma
2 Locations available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
Conditions: Melanoma
1 Location available
- Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Stage IV Melanoma That Has Been Removed By Surgery
Conditions: Melanoma (Skin)
1 Location available
- Aldesleukin With or Without Aflibercept in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Melanoma (Skin)
11 Locations available
- Lapatinib in Stage IV Melanoma With ERBB4 Mutations
Conditions: Malignant Melanoma
3 Locations available
- Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
Conditions: Melanoma
1 Location available
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
447 Locations available
- Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Conditions: Melanoma
1 Location available
- Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma
Conditions: Unresectable Stage III or IV Melanoma
7 Locations available
- Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
Conditions: Melanoma
1 Location available
- Phase II FANG in Advanced Melanoma
Conditions: Advanced Melanoma
1 Location available
- Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Conditions: Melanoma
8 Locations available
- Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
Conditions: Metastatic Cancer - Melanoma
1 Location available
- Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Intraocular Melanoma
1 Location available
- Optical Imaging of Skin Cancers for Margin Delineation of Non-melanoma Skin Cancers
Conditions: Skin Cancer
1 Location available
- Vaccination Plus Ontak in Patients With Metastatic Melanoma
Conditions: Melanoma
1 Location available
- Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Conditions: Malignant Melanoma
2 Locations available
- Interferon Alfa-2b in Treating Patients Who Have Undergone Surgery for High-Risk or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver
Conditions: Melanoma - Liver Metastasis
1 Location available
- Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Conditions: Familial Pancreatic Cancer
1 Location available
- Melanoma Molecular Profiling Analysis
Conditions: Melanoma
1 Location available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Conditions: Melanoma (Skin)
1 Location available
- Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma
Conditions: Melanoma
1 Location available
- An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Conditions: Melanoma
3 Locations available
- Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
Conditions: Skin Cancer - Metastatic Melanoma
1 Location available
- RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
Conditions: Uveal Melanoma
1 Location available
- Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer
Conditions: Melanoma - Metastatic Kidney Cancer
2 Locations available
- Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Conditions: Melanoma - Metastatic Melanoma - Solid Tumor
2 Locations available
- A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
Conditions: Melanoma
2 Locations available
- Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Conditions: Melanoma
1 Location available
- Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Conditions: Non-Melanoma Skin Cancer
1 Location available
- SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Conditions: Stage IV Uveal Melanoma
1 Location available
- Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
Conditions: Melanoma
1 Location available
- Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
Conditions: Melanoma
1 Location available
- RADVAX: A Stratified Phase I/II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
Conditions: Melanoma
1 Location available
- A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients W
Conditions: Metastatic Melanoma
2 Locations available
- Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma - Choroidal Melanoma - Uveal Melanoma
1 Location available
- High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes
Conditions: Melanoma
1 Location available
- Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
Conditions: Neoplastic Syndrome - Non-Melanomatous Skin Cancer
2 Locations available
- Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Conditions: Intraocular Melanoma
1 Location available
- Prospective Measurement of Post-Treatment Lymphedema
Conditions: Melanoma
1 Location available
- Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Conditions: Leukemia - Non-melanomatous Skin Cancer
3 Locations available
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Conditions: Basal Cell Carcinoma - Melanoma - Squamous Cell Carcinoma - Non-Malignant Skin Disorders
1 Location available
- Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
Conditions: Melanoma - Non-Small Cell Lung Cancer - Lung Cancer, Non-Small Cell
1 Location available
- IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Conditions: Breast Cancer - Lung Cancer - Melanoma - Pancreatic Cancer - Solid Tumors
1 Location available
- Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
Conditions: Melanoma
1 Location available
- Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Malignant Melanoma
2 Locations available
- Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size - Ciliary Body and Choroid Melanoma, Small Size - Iris Melanoma - Recurrent Intraocular Melanoma
1 Location available
- IL15 Dendritic Cell Vaccine for Patients With Resected Stage IIIc and Stage IV Melanoma
Conditions: Stage IIIc/IV Melanoma
1 Location available
- Treating Metastatic Cancer With Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes
Conditions: Metastatic Cancer - Metastatic Melanoma - Renal Cancer
1 Location available
- A Study of RO5185426 And GDC-0973 in Patients With BRAF-Mutation Positive Metastatic Melanoma
Conditions: Malignant Melanoma
6 Locations available
- Prospective Randomized Study of Cell Therapy for Metastatic Melanoma Using Short-Term Cultured Tumor Infiltrating Lymphocytes Plus IL-2 Following Eith
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Me
Conditions: Melanoma
1 Location available
- Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Conditions: Recurrent Melanoma - Stage IV Melanoma
1 Location available
- Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination
Conditions: Melanoma
2 Locations available
- Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
Conditions: Breast Cancer - Genitourinary Cancer - Malignant Female Reproductive System Neoplasm - Melanoma - Sarcoma
1 Location available
- Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Conditions: Melanoma
5 Locations available
- A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
Conditions: Melanoma
1 Location available
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors - Malignant Melanoma - Hematological Malignancies - Myelogenous Leukemia, Chronic - Leukemia, Lymphoblastic, Acute
1 Location available
- Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Conditions: Metastatic Melanoma - Renal Cell Cancer
1 Location available
- Melanoma Biomarker Study
Conditions: Metastatic Melanoma
1 Location available
- Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
Conditions: Eye Disease - Melanoma
1 Location available
- Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Conditions: Metastatic Melanoma
1 Location available
- Evaluation of Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy
Conditions: Metastatic Melanoma
1 Location available
- Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma
Conditions: Melanoma
1 Location available
- Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
Conditions: Metastatic Melanoma - Metastatic Renal Cell Cancer - Metastatic Cancer
1 Location available
- Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma - Cutaneous Melanoma
2 Locations available
- Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)
Conditions: Melanoma
1 Location available
- Stage IV Surgery Versus Best Medical Therapy
Conditions: Stage IV Resectable Melanoma
15 Locations available
- A Phase I/II Study of TPI 287 - Temozolomide Combination in Melanoma
Conditions: Melanoma
1 Location available
- Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Melanoma (Skin)
1 Location available
- Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
Conditions: Cutaneous Melanoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Tumor Cell Vaccines and ISCOMATRIX(Trademark) With Chemotherapy After Tumor Removal
Conditions: Sarcoma - Melanoma - Epithelial Malignancies - Pleural Malignancy
1 Location available
- Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Conditions: Malignant Melanoma, Metastatic
1 Location available
- Study to Assess the Safety and Immunological Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
Conditions: Melanoma
1 Location available
- A Study Of Surgical Radiation Shielding With Vitrectomy And Silicone Oil Tamponade For The Protection Of Radiation Induced Ocular Injury
Conditions: Unilateral Choroidal Melanoma
1 Location available
- Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
Conditions: Mestatic Melanoma - Skin Cancer
1 Location available
- Trial of pIL-12 Electroporation Malignant Melanoma
Conditions: Melanoma
3 Locations available
- Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutatio
Conditions: Malignant Melanoma
2 Locations available
- A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With INCB024360 or Placebo in Subjects With Unresectable or Met
Conditions: Metastatic Melanoma
2 Locations available
- Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignanc
Conditions: Melanoma
1 Location available
- Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
Conditions: Melanoma
4 Locations available
- Selumetinib With or Without Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or
Conditions: Melanoma (Skin)
4 Locations available
- Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresect
Conditions: Wild Type BRAF Stage IV Melanoma - Unresectable Stage III Melanoma
1 Location available
- Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Head and Neck Cancer - Intraocular Melanoma - Melanoma (Skin) - Non-melanomatous Skin Cancer - Precancerous Condition
1 Location available
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
Conditions: Cutaneous Melanoma
36 Locations available
- Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
Conditions: Melanoma
39 Locations available
- Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
Conditions: Melanoma (Skin)
1 Location available
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Lung Cancer - Melanoma - Non-Hodgkin's Lymphoma - Uterine Cancer - CORPUS UTERI,ENDOMETRIUM - LUNG - OVARY
1 Location available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Conditions: Intraocular Melanoma
1 Location available
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch Studies
Conditions: Melanoma - Adenocarcinoma - Carcinoma NOS - Neuroendocrine Tumors
1 Location available
- Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
Conditions: Melanoma
1 Location available
- LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma
Conditions: Stage IV Melanoma
3 Locations available
- Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma
Conditions: Recurrent Melanoma - Stage IV Melanoma
1 Location available
- IMCgp100 in Advanced Unresectable Melanoma
Conditions: Melanoma - Advanced Disease - Unresectable
1 Location available
- Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Conditions: NY-ESO-1 Positive Solid Tumors or Melanoma
2 Locations available
- A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients Wi
Conditions: Malignant Melanoma
2 Locations available
- PET Imaging of Patients With Melanoma Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
Conditions: Newly Diagnosed or Recurrent Metastatic Melanoma Patients
1 Location available
- IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
Conditions: Malignant Melanoma
1 Location available
- Nuclear and Near-Infrared (NIR) Imaging in Melanoma
Conditions: Melanoma
1 Location available
- Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
Conditions: Metastatic Melanoma
1 Location available
- Phase II Trial of Mitogen Activated Protein (MAP) Kinase Inhibition With AZD6244 and MK-2206 (Akt Inhibitor) in Patients With Relapsed (BRAF) V600E Mu
Conditions: Melanoma
1 Location available
- A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma
Conditions: Malignant Melanoma
1 Location available
- Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Conditions: Colon Cancer - Head and Neck Cancer - Lung Cancer - Lymphoma - Malignant Neoplasm - Melanoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Conditions: Melanoma
1 Location available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
Conditions: Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Intraocular Melanoma
1 Location available
- Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Conditions: Melanoma - Malignant Melanoma
16 Locations available
- Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
Conditions: Melanoma
1 Location available
- Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation
Conditions: Healthy, no Evidence of Disease - Non-melanomatous Skin Cancer
1 Location available
- A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotrheraphy Regimen
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- Autonomic Phenotype Before and After Akt Inhibition
Conditions: Diagnosis of Melanoma
1 Location available
|